the importance of minimal residual disease in all
Published 8 years ago • 263 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
3:22
the main prognostic factors and why minimal residual disease is becoming crucial in multiple myeloma
-
3:01
minimal residual disease: a key determinant of all treatment response
-
1:50
treatment of minimal residual disease in aml patients
-
2:57
when is the optimal time to measure minimal residual disease (mrd) in myeloma patients?
-
3:28
bringing minimal residual disease (mrd) measurement to the clinic
-
11:33
treatment algorithm for low-risk mds
-
11:53
the optimal treatment of lower risk mds
-
34:46
game-changing potential of mrd in hematological malignancies: overview and importance
-
1:46
importance of mrd monitoring in all
-
3:35
analysis from most: disease progression and leukemic transformation in lower-risk myelofibrosis
-
2:35
mrd focus: why measurable residual disease testing is the future
-
3:35
minimal residual disease (mrd) as a prognostic factor for acute myeloid leukemia (aml)
-
2:22
next-generation methodologies: the future for mrd monitoring in all?
-
4:20
an overview of minimal residual disease testing
-
1:41
novel technologies to detect minimal residual disease (mrd)
-
0:34
medical animation: multiple myeloma minimal residual disease (mrd)
-
4:30
measurable residual disease in aml
-
3:07
minimal residual disease (mrd)
-
1:06
origins and treatment options for anemia in myelofibrosis
-
4:44
minimal residual disease (mrd) | high impact topic (hit)
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:20
the current standard of care for patients with lower-risk mds